Sight Sciences, Inc.

NASDAQ:SGHT

Medical - Devices

Healthcare
$10.62 +2.89%

+$0.15 today

Market cap
$590.25M
Beta
2.41
P/E (TTM)
-7.5
EPS (TTM)
-$0.69
52W Low $3.11High $9.24

Volume 0.38M

Average 0.25M

Income Statement

Follow revenue through to earnings.

Revenue

$77.36M

FY 2025 · Annual

-3.1% YoY

Operating Income

-$37.10M

FY 2025 · Annual

Net Income

-$38.43M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue48.96M71.33M81.06M79.87M77.36M
Cost of Revenue8.61M12.36M11.88M11.58M10.7M
Gross Profit40.35M58.97M69.18M68.29M66.67M
Gross Margin82.4%82.7%85.3%85.5%86.2%
Research & Development15.63M22.86M17.56M17.99M14.61M
Selling, General & Admin76.19M120.07M108.89M100.83M89.16M
Operating Expenses91.82M142.92M126.45M118.82M103.77M
Depreciation & Amortization1.2M1.25M614K712K487K
EBITDA(57.21M)(80.48M)(49.42M)(45.9M)(32.79M)
EBITDA Margin-116.8%-112.8%-61.0%-57.5%-42.4%
Operating Income(51.48M)(83.95M)(57.27M)(50.53M)(37.1M)
Operating Margin-105.2%-117.7%-70.7%-63.3%-48.0%
Interest Income00003.97M
Interest Expense4.37M4.47M5.41M4.66M5.14M
Other Income / Expenses(11.29M)(2.24M)1.84M(739K)(1.32M)
Income Before Tax(62.77M)(86.2M)(55.44M)(51.27M)(38.42M)
Pre-Tax Margin-128.2%-120.8%-68.4%-64.2%-49.7%
Income Tax Expense188K47K110K236K10K
Net Income(62.96M)(86.24M)(55.55M)(51.51M)(38.43M)
Net Margin-128.6%-120.9%-68.5%-64.5%-49.7%
EPS (Basic)(1.33)(1.80)(1.14)(1.03)(0.74)
EPS (Diluted)(1.33)(1.80)(1.14)(1.03)(0.74)
Weighted Avg Shares47.5M47.85M48.63M50.13M52.15M
Weighted Avg Shares (Diluted)47.5M47.85M48.63M50.13M52.15M

SGHT Earnings Waterfall · TTM

NASDAQ:SGHT · Revenue to Net Income

Key Ratios

EPS$-0.71
Gross Margin86.2%
Net Margin-47.1%
P/E Ratio-9.8
P/S Ratio12.7

Analysis

$79.6M of revenue converted into -$37.3M of net income for the selected period. Gross margin is 86.2% and net margin is -47.1%, showing how much revenue survives after costs and taxes. EPS is $-0.71, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026

How much revenue does SGHT generate?

Sight Sciences, Inc. (SGHT) reported $77.36M of revenue in fiscal 2025.

Is SGHT profitable?

Sight Sciences, Inc. (SGHT) reported -$38.43M of net income, with a net margin of -49.7%.